Wang, Jun
Sun, Jingwei
Liu, Linda N.
Flies, Dallas B.
Nie, Xinxin
Toki, Maria
Zhang, Jianping
Song, Chang
Zarr, Melissa
Zhou, Xu http://orcid.org/0000-0002-1692-6823
Han, Xue
Archer, Kristina A.
O’Neill, Thomas
Herbst, Roy S.
Boto, Agedi N.
Sanmamed, Miguel F.
Langermann, Solomon
Rimm, David L. http://orcid.org/0000-0001-5820-4397
Chen, Lieping http://orcid.org/0000-0002-6825-3069
Article History
Received: 22 March 2018
Accepted: 24 January 2019
First Online: 4 March 2019
Competing interests
: In the past 12 months, L.C. has been a consultant/advisory board member for NextCure, AstraZenca, Pfizer, Junshi, Vcanbio and GenomiCare. L.C. is a scientific founder of NextCure and Tayu Biotech Group and has sponsored research grants from NextCure, Pfizer and Boehringer Ingelheim. D.R. is a consultant/advisory board member for Amgen, AstraZeneca, Agendia, Biocept, Bristol-Myers Squibb, Cell Signaling Technology, Cepheid, Daiichi Sankyo, Merck, NanoString, Perkin Elmer, PAIGE and Ultivue and has sponsored research grants from AstraZeneca, Cepheid, Navigate/Novartis, NextCure, Lilly, Ultivue and Perkin Elmer. R.H. is a consultant/advisory board member for Abbvie Pharmaceuticals, AstraZeneca, Biodesix, Bristol-Myers Squibb, Eli Lilly and Company, EMD Serrano, Genentech/Roche, Heat Biologics, Infinity Pharmaceuticals, Junshi Pharmaceuticals, Loxo Oncology, Merck and Company, Nektar, Neon Therapeutics, NextCure, Novartis, Pfizer, Sanofi, Seattle Genetics, Shire PLC, Spectrum Pharmaceuticals, Symphogen, TESARO and has sponsored research grants from AstraZeneca, Eli Lilly and Company, Merck and Company, and is a board member (non-executive/independent) for Junshi Pharmaceuticals. There are patent applications pending related to this work.